Physician profile
Ryan D Meek
NPI 1275923146
$6,535.82
in general payments reported to CMS, 2019-2025
10 companies · $347 in 2025
The $347 reported for 2025 was more than what 75% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $130 · 2022: $3,428 · 2023: $903 · 2024: $1,728 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,619 · Food and Beverage: $1,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,618.71 |
| Food and Beverage | $1,359.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,365.65 | 2022-2025 | Indigo System, Penumbra Coil 400 |
| Terumo Medical Corporation | $1,347.68 | 2022-2024 | Azur Cx Detachable |
| Stryker Corporation | $1,063.34 | 2024-2025 | Spinejack, Ivas, Optablate |
| Boston Scientific Corporation | $293.89 | 2021-2025 | Cryoablation Needles, Embold Fibered |
| Cook Medical LLC | $266.03 | 2022-2025 | Rosen, Zilver Ptx |
| Inari Medical, INC. | $67.69 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Angiodynamics, INC. | $44.22 | 2023 | Smart Port Ct, Duraflow |
| Abbott Laboratories | $40.15 | 2023-2025 | Perclose Prostyle, Emboshield Nav6 |
| Cordis US Corp. | $28.75 | 2024 | Mynx Control |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.42 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Meek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.